胃饥饿素对老龄小鼠禁食诱导的肌肉萎缩的保护作用
该研究在老龄胃饥饿素基因敲除小鼠中观察禁食诱导的肌肉丢失,发现缺失胃饥饿素加重肌肉萎缩并改变线粒体功能与肠道菌群;酰化与非酰化胃饥饿素均可提升肌细胞线粒体呼吸能力、促进肌肉合成基因并抑制降解基因,非酰化胃饥饿素因不引起肥胖相关副作用而成为肌少症潜在治疗选择。
要点
- 老龄胃饥饿素缺失小鼠禁食后肌肉丢失加重,MyoD表达下降、MuRF1表达上升。
- 酰化与非酰化胃饥饿素均能提高肌细胞线粒体呼吸能力并改善肌肉合成/降解基因表达。
- 非酰化胃饥饿素无酰化胃饥饿素的致肥胖副作用,可能是肌少症有吸引力的治疗选项。
核心结论
- 胃饥饿素通过肌肉内在与外在机制在维持老龄肌肉中起重要作用。
- 酰化与非酰化胃饥饿素均增强肌肉合成代谢并对肌肉萎缩发挥保护作用。
- 非酰化胃饥饿素因不引起酰化胃饥饿素所致的致肥胖副作用,是肌少症有吸引力的治疗选项。
研究设计与样本
- 研究在老龄胃饥饿素基因敲除(Ghrl-/-)小鼠中观察禁食诱导的肌肉丢失。
- 研究检测了肌肉C2C12细胞的线粒体呼吸能力及禁食老龄Ghrl-/-小鼠肌肉中肌源性与降解基因表达。
- 研究分析了Ghrl-/-小鼠的肠道菌群组成。
主要发现
- 老龄Ghrl-/-小鼠禁食诱导的肌肉丢失加重,MyoD表达降低、MuRF1表达升高,并伴线粒体功能改变。
- 酰化胃饥饿素与非酰化胃饥饿素处理均显著增加肌肉C2C12细胞的线粒体呼吸能力。
- 酰化与非酰化胃饥饿素处理有效增加禁食老龄Ghrl-/-小鼠肌肉中的肌源性基因并减少降解基因,可能通过刺激胰岛素与腺苷酸活化蛋白激酶(AMPK)通路。
- Ghrl-/-小鼠呈现促炎性肠道菌群特征,产丁酸菌Roseburia与ClostridiumXIVb减少。
临床怎么用
- 非酰化胃饥饿素因无致肥胖副作用,可作为肌少症治疗的候选方向。
- 胃饥饿素相关通路(胰岛素与AMPK)可能成为维护老龄肌肉的干预靶点。
局限性
- 研究为小鼠与细胞实验,结论向老年人群外推需进一步临床验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Sarcopenia is the aging-associated progressive loss of skeletal muscle; however, the pathogenic mechanism of sarcopenia is not clear. The orexigenic hormone ghrelin stimulates growth hormone secretion, increases food intake, and promotes adiposity. Here we showed that fasting-induced muscle loss was exacerbated in old ghrelin-null (Ghrl-/-) mice, exhibiting decreased expression of myogenic regulator MyoD and increased expression of protein degradation marker MuRF1, as well as altered mitochondrial function. Moreover, acylated ghrelin and unacylated ghrelin treatments significantly increased mitochondrial respiration capacity in muscle C2C12 cells. Consistently, acylated ghrelin and unacylated ghrelin treatments effectively increased myogenic genes and decreased degradation genes in the muscle in fasted old Ghrl-/- mice, possibly by stimulating insulin and adenosine monophosphate-activated protein kinase pathways. Furthermore, Ghrl-/- mice showed a profile of pro-inflammatory gut microbiota, exhibiting reduced butyrate-producing bacteria Roseburia and ClostridiumXIVb. Collectively, our results showed that ghrelin has a major role in the maintenance of aging muscle via both muscle-intrinsic and -extrinsic mechanisms. Acylated ghrelin and unacylated ghrelin enhanced muscle anabolism and exerted protective effects for muscle atrophy. Because unacylated ghrelin is devoid of the obesogenic side effect seen with acylated ghrelin, it represents an attractive therapeutic option for sarcopenia.
引用
- Wu CS, Wei Q, Wang H, et al. Protective Effects of Ghrelin on Fasting-Induced Muscle Atrophy in Aging Mice. J Gerontol A Biol Sci Med Sci. 2020. PMID: 30407483. doi:10.1093/gerona/gly256
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。